相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
Norihiro Nishimoto et al.
Modern Rheumatology (2014)
TOCILIZUMAB (TCZ) MONOTHERAPY IS SUPERIOR TO ADALIMUMAB (ADA) MONOTHERAPY IN REDUCING DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): 24-WEEK DATA FROM THE PHASE 4 ADACTA TRIAL
C. Gabay et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
Mark C. Genovese et al.
JOURNAL OF RHEUMATOLOGY (2013)
Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors
Misato Hashizume et al.
CYTOKINE (2012)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo Study
Jeffrey K. Lee et al.
PLOS ONE (2012)
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
Elena Myasoedova et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2011)
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
Deborah P. M. Symmons et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Integrated safety in tocilizumab clinical trials
Michael H. Schiff et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor
Misato Hashizume et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
G. Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
T. E. Toms et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
E. Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
A. Gonzalez et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis - A cohort and nested case-control analysis
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2008)
Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis
Tracey M. Farragher et al.
ARTHRITIS AND RHEUMATISM (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
Antonio Naranjo et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review
John Danesh et al.
PLOS MEDICINE (2008)
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Relaxing the rule of ten events per variable in logistic and Cox regression
Eric Vittinghoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis
H. Maradit-Kremers et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Patterns of cardiovascular risk in rheumatoid arthritis
D. H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Antirheumatic drug use and the risk of acute myocardial infarction
Samy Suissa et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family
M Mihara et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements
H Gierens et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
